SC 13G
SABBY 13G AYTU 3.12.20
- Company
- AYTU BIOPHARMA, INC
- Filed
- March 12, 2020
- Accession Number
- 0001535610-20-000080
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →